Large Scale RNAi Reveals the Requirement of Nuclear Envelope Breakdown for Nuclear Import of Human Papillomaviruses

English version České info

Certain human papillomaviruses (HPV) are the etiological cause of cervical cancers and other epithelial tumors. Recent advances in the development of anti-HPV vaccines and their increasing deployment provide hope for a significant decrease of these cancers in the future. However, many details of the transmission of HPV between infected and uninfected individuals are still not well understood. In particular, the multistep process of entry into host cells is only partially characterized. Here, we used a systematic RNAi silencing approach to identify host cell proteins required during HPV16 infection, the most prevalent cancer-causing HPV. Our results indicated that HPV entry requires cells to divide. Cell division is important, since it removes the barrier between the nucleoplasm and the cytosol, so that the virus can access the nucleus for transcription and replication. Our study provides new mechanistic insights into the entry process of an important pathogen, and explains why it can only infect the stem cells or transiently amplifying cells of human skin or mucosa. This work also highlights a novel nuclear import strategy for DNA viruses, which typically use the nuclear import machinery to access the nucleoplasm for infection, Thus, HPV entry displays another unique aspect uncommon to most other viruses.

Vyšlo v časopise: Large Scale RNAi Reveals the Requirement of Nuclear Envelope Breakdown for Nuclear Import of Human Papillomaviruses. PLoS Pathog 10(5): e32767. doi:10.1371/journal.ppat.1004162
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004162

Souhrn

Zdroje

1. DoorbarJ, QuintW, BanksL, BravoIG, StolerM, et al. (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30 Suppl 5F55–70.

2. BoschFX, de SanjoseS (2003) Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr (31): 3–13.

3. SchillerJT, CastellsagueX, GarlandSM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30 Suppl 5F123–138.

4. BuckCB, ChengN, ThompsonCD, LowyDR, StevenAC, et al. (2008) Arrangement of L2 within the Papillomavirus capsid. J Virol 82 : 5190–5197.

5. BuckCB, PastranaDV, LowyDR, SchillerJT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78 : 751–757.

6. BuckCB, ThompsonCD, PangYY, LowyDR, SchillerJT (2005) Maturation of papillomavirus capsids. J Virol 79 : 2839–2846.

7. Buck CB, Thompson CD (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Chapter 26: Unit 26 21.

8. GiroglouT, FlorinL, SchaferF, StreeckRE, SappM (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75 : 1565–1570.

9. JohnsonKM, KinesRC, RobertsJN, LowyDR, SchillerJT, et al. (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83 : 2067–2074.

10. JoyceJG, TungJS, PrzysieckiCT, CookJC, LehmanED, et al. (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274 : 5810–5822.

11. KinesRC, ThompsonCD, LowyDR, SchillerJT, DayPM (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A 106 : 20458–20463.

12. CerqueiraC, LiuY, KuhlingL, ChaiW, HafeziW, et al. (2013) Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol 15 : 1818–1836.

13. RichardsKF, Bienkowska-HabaM, DasguptaJ, ChenXS, SappM (2013) Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J Virol 87 : 11426–11437.

14. SelinkaHC, FlorinL, PatelHD, FreitagK, SchmidtkeM, et al. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81 : 10970–10980.

15. DayPM, GambhiraR, RodenRB, LowyDR, SchillerJT (2008) Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol 82 : 4638–4646.

16. Bienkowska-HabaM, PatelHD, SappM (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5: e1000524.

17. RichardsRM, LowyDR, SchillerJT, DayPM (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103 : 1522–1527.

18. DayPM, LowyDR, SchillerJT (2008) Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol 82 : 12565–12568.

19. SelinkaHC, GiroglouT, NowakT, ChristensenND, SappM (2003) Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol 77 : 12961–12967.

20. DayPM, ThompsonCD, BuckCB, PangYY, LowyDR, et al. (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81 : 8784–8792.

21. SurviladzeZ, DziduszkoA, OzbunMA (2012) Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog 8: e1002519.

22. WoodhamAW, Da SilvaDM, SkeateJG, RaffAB, AmbrosoMR, et al. (2012) The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One 7: e43519.

23. EvanderM, FrazerIH, PayneE, QiYM, HengstK, et al. (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71 : 2449–2456.

24. McMillanNA, PayneE, FrazerIH, EvanderM (1999) Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 261 : 271–279.

25. YoonCS, KimKD, ParkSN, CheongSW (2001) alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 283 : 668–673.

26. DziduszkoA, OzbunMA (2013) Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol 87 : 7502–7515.

27. SpodenG, FreitagK, HusmannM, BollerK, SappM, et al. (2008) Clathrin -⁠ and caveolin-independent entry of human papillomavirus type 16—involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 3: e3313.

28. SchefferKD, GawlitzaA, SpodenGA, ZhangXA, LambertC, et al. (2013) Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol 87 : 3435–3446.

29. FlorinL, SappM, SpodenGA (2012) Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol 201 : 437–448.

30. DayPM, LowyDR, SchillerJT (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307 : 1–11.

31. SchelhaasM, ShahB, HolzerM, BlattmannP, KuhlingL, et al. (2012) Entry of human papillomavirus type 16 by actin-dependent, clathrin -⁠ and lipid raft-independent endocytosis. PLoS Pathog 8: e1002657.

32. SpodenG, KuhlingL, CordesN, FrenzelB, SappM, et al. (2013) Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol 87 : 7765–7773.

33. DayPM, ThompsonCD, SchowalterRM, LowyDR, SchillerJT (2013) Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol 87 : 3862–3870.

34. LipovskyA, PopaA, PimientaG, WylerM, BhanA, et al. (2013) Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A 110 : 7452–7457.

35. Bienkowska-HabaM, WilliamsC, KimSM, GarceaRL, SappM (2012) Cyclophilins Facilitate Dissociation of the HPV16 Capsid Protein L1 from the L2/DNA Complex Following Virus Entry. J Virol 86 : 9875–87.

36. KamperN, DayPM, NowakT, SelinkaHC, FlorinL, et al. (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80 : 759–768.

37. IshiiY, TanakaK, KondoK, TakeuchiT, MoriS, et al. (2010) Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. Virology 406 : 181–188.

38. DayPM, BakerCC, LowyDR, SchillerJT (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101 : 14252–14257.

39. PyeonD, PearceSM, LankSM, AhlquistP, LambertPF (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5: e1000318.

40. CherryS (2009) What have RNAi screens taught us about viral-host interactions? Curr Opin Microbiol 12 : 446–452.

41. SnijderB, SacherR, RamoP, LiberaliP, MenchK, et al. (2012) Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 8 : 579.

42. FothergillT, McMillanNA (2006) Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology 352 : 319–328.

43. SchneiderMA, SpodenGA, FlorinL, LambertC (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13 : 32–46.

44. SurviladzeZ, SterkRT, DeHaroSA, OzbunMA (2013) Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol 87 : 2508–2517.

45. MercerJ, SnijderB, SacherR, BurkardC, BleckCK, et al. (2012) RNAi screening reveals proteasome -⁠ and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2 : 1036–1047.

46. Huang daW, ShermanBT, LempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4 : 44–57.

47. SzklarczykD, FranceschiniA, KuhnM, SimonovicM, RothA, et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561–568.

48. SteigemannP, WurzenbergerC, SchmitzMH, HeldM, GuizettiJ, et al. (2009) Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 136 : 473–484.

49. HeimR, PrasherDC, TsienRY (1994) Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci U S A 91 : 12501–12504.

50. MayerTU, KapoorTM, HaggartySJ, KingRW, SchreiberSL, et al. (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286 : 971–974.

51. KapoorTM, MayerTU, CoughlinML, MitchisonTJ (2000) Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J Cell Biol 150 : 975–988.

52. GuttingerS, LaurellE, KutayU (2009) Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol 10 : 178–191.

53. DrobniP, MistryN, McMillanN, EvanderM (2003) Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry. Virology 310 : 163–172.

54. SappM, KrausU, VolpersC, SnijdersPJ, WalboomersJM, et al. (1994) Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol 75 (Pt 12): 3375–3383.

55. WhittakerGR, KannM, HeleniusA (2000) Viral entry into the nucleus. Annu Rev Cell Dev Biol 16 : 627–651.

56. GreberUF, FassatiA (2003) Nuclear import of viral DNA genomes. Traffic 4 : 136–143.

57. CohenS, AuS, PanteN (2011) How viruses access the nucleus. Biochim Biophys Acta 1813 : 1634–1645.

58. KwantMM, van der VlietPC (1980) Differential effect of aphidicolin on adenovirus DNA synthesis and cellular DNA synthesis. Nucleic Acids Res 8 : 3993–4007.

59. SpadariS, FocherF, SalaF, CiarrocchiG, KochG, et al. (1985) Control of cell division by aphidicolin without adverse effects upon resting cells. Arzneimittelforschung 35 : 1108–1116.

60. OjalaPM, SodeikB, EbersoldMW, KutayU, HeleniusA (2000) Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol 20 : 4922–4931.

61. HafeziW, LorentzenEU, EingBR, MullerM, KingNJ, et al. (2012) Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog 8: e1002679.

62. WaltherTC, FornerodM, PickersgillH, GoldbergM, AllenTD, et al. (2001) The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins. EMBO J 20 : 5703–5714.

63. SuzukiY, CraigieR (2007) The road to chromatin -⁠ nuclear entry of retroviruses. Nat Rev Microbiol 5 : 187–196.

64. PorwalM, CohenS, SnoussiK, Popa-WagnerR, AndersonF, et al. (2013) Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis. PLoS Pathog 9: e1003671.

65. HeldM, SchmitzMH, FischerB, WalterT, NeumannB, et al. (2010) CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging. Nat Methods 7 : 747–754.

66. SeksekO, BiwersiJ, VerkmanAS (1997) Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus. J Cell Biol 138 : 131–142.

67. DarshanMS, LucchiJ, HardingE, MoroianuJ (2004) The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J Virol 78 : 12179–12188.

68. SchmitzMH, HeldM, JanssensV, HutchinsJR, HudeczO, et al. (2010) Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 12 : 886–893.

69. TanudjiM, ShoemakerJ, L'ItalienL, RussellL, ChinG, et al. (2004) Gene silencing of CENP-E by small interfering RNA in HeLa cells leads to missegregation of chromosomes after a mitotic delay. Mol Biol Cell 15 : 3771–3781.

70. BushmanFD, MalaniN, FernandesJ, D'OrsoI, CagneyG, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.

71. PandaD, CherryS (2012) Cell-based genomic screening: elucidating virus-host interactions. Curr Opin Virol 2 : 784–792.

72. FlorinL, BeckerKA, LambertC, NowakT, SappC, et al. (2006) Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol 80 : 6691–6696.

73. BordeauxJ, ForteS, HardingE, DarshanMS, KlucevsekK, et al. (2006) The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J Virol 80 : 8259–8262.

74. ElisE, EhrlichM, Prizan-RavidA, Laham-KaramN, BacharachE (2012) p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS Pathog 8: e1003103.

75. McBrideAA (2013) The papillomavirus E2 proteins. Virology 445 : 57–79.

76. BarksdaleSK, BakerCC (1993) Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol 67 : 5605–5616.

77. PastranaDV, BuckCB, PangYY, ThompsonCD, CastlePE, et al. (2004) Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321 : 205–216.

78. RobertsJN, BuckCB, ThompsonCD, KinesR, BernardoM, et al. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13 : 857–861.

79. PastranaDV, GambhiraR, BuckCB, PangYY, ThompsonCD, et al. (2005) Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology 337 : 365–372.

80. SchelhaasM, EwersH, RajamakiML, DayPM, SchillerJT, et al. (2008) Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog 4: e1000148.

81. McLaughlin-DrubinME, MeyersC (2005) Propagation of infectious, high-risk HPV in organotypic “raft” culture. Methods Mol Med 119 : 171–186.

82. ConwayMJ, CruzL, AlamS, ChristensenND, MeyersC (2011) Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS One 6: e22427.

83. CerqueiraC, LiuY, KuhlingL, ChaiW, HafeziW, et al. (2013) Heparin increases the infectivity of Human Papillomavirus Type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol 15 : 1818–36.

84. EngelS, HegerT, ManciniR, HerzogF, KartenbeckJ, et al. (2011) Role of endosomes in simian virus 40 entry and infection. J Virol 85 : 4198–4211.

85. JonesTR, KangIH, WheelerDB, LindquistRA, PapalloA, et al. (2008) CellProfiler Analyst: data exploration and analysis software for complex image-based screens. BMC Bioinformatics 9 : 482.

86. CarpenterAE, JonesTR, LamprechtMR, ClarkeC, KangIH, et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7: R100.